摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(4-(2,5-Dimethyl-3-phenylpyrazolo[1,5-a]pyrimidin-7-yl)piperazin-1-yl)ethanol

中文名称
——
中文别名
——
英文名称
2-(4-(2,5-Dimethyl-3-phenylpyrazolo[1,5-a]pyrimidin-7-yl)piperazin-1-yl)ethanol
英文别名
2-[4-(2,5-dimethyl-3-phenylpyrazolo[1,5-a]pyrimidin-7-yl)piperazin-1-yl]ethanol
2-(4-(2,5-Dimethyl-3-phenylpyrazolo[1,5-a]pyrimidin-7-yl)piperazin-1-yl)ethanol化学式
CAS
——
化学式
C20H25N5O
mdl
——
分子量
351.4
InChiKey
AMGSSOTZVXYAGB-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.3
  • 重原子数:
    26
  • 可旋转键数:
    4
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.4
  • 拓扑面积:
    56.9
  • 氢给体数:
    1
  • 氢受体数:
    5

文献信息

  • Methods and compositions for KRAS inhibitors
    申请人:The Board of Regents, The University of Texas System
    公开号:US11141418B1
    公开(公告)日:2021-10-12
    In one aspect, the disclosure relates to compounds that are inhibitors of KRAS, and the disclosed compounds are allosteric inhibitors of KRAS which render them extremely useful for therapeutic intervention in a variety of disorders and diseases in which inhibition of DHODH can be clinically useful, e.g., cancer. In various aspects, the disclosed compounds are substituted 7-(piperazin-1-yl)pyrazolo[1,5-a]pyrimidine analogs. In further aspects, the disclosed compounds can be used in methods of treating a cancer. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present disclosure.
    在一个方面,本公开涉及的化合物是KRAS的抑制剂,所公开的化合物是KRAS的异构抑制剂,这使得它们在各种疾病的治疗干预中极为有用,在这些疾病中,抑制DHODH在临床上是有用的,例如癌症。在各个方面,所公开的化合物是取代的 7-(哌嗪-1-基)吡唑并[1,5-a]嘧啶类似物。在进一步的方面,所公开的化合物可用于治疗癌症的方法中。本摘要旨在作为在特定技术领域进行搜索的扫描工具,并非对本公开内容的限制。
  • METHODS AND COMPOSITIONS FOR KRAS INHIBITORS
    申请人:The Board of Regents of the University of Texas System
    公开号:US20210401845A1
    公开(公告)日:2021-12-30
    In one aspect, the disclosure relates to compounds that are inhibitors of KRAS, and the disclosed compounds are allosteric inhibitors of KRAS which render them extremely useful for therapeutic intervention in a variety of disorders and diseases in which inhibition of DHODH can be clinically useful, e.g., cancer. In various aspects, the disclosed compounds are substituted 7-(piperazin-1-yl)pyrazolo[1,5-a]pyrimidine analogs. In further aspects, the disclosed compounds can be used in methods of treating a cancer. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present disclosure.
查看更多